Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks
Máté Á. Demény, László Virág
Cancers (2021) Vol. 13, Iss. 9, pp. 2042-2042
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies
Jixuan Gao, Hilda A. Pickett
Nature reviews. Cancer (2022) Vol. 22, Iss. 9, pp. 515-532
Closed Access | Times Cited: 139
Role of hypoxia in cellular senescence
Haoyu Gao, Eugenie Nepovimová, Zbyněk Heger, et al.
Pharmacological Research (2023) Vol. 194, pp. 106841-106841
Open Access | Times Cited: 56
Recent strategies to overcome breast cancer resistance
Muhammad Muzamil Khan, Satya Siva Kishan Yalamarty, Bharat Ashok Rajmalani, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104351-104351
Open Access | Times Cited: 18
Plant Foods and Their Bioactives as Dietary Enhancers for Colon Cancer Treatment with 5-Fluorouracil
Zhongming Yang, Carlos L. Céspedes, Zhongguo Yang, et al.
Food Reviews International (2025), pp. 1-50
Closed Access | Times Cited: 6
PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities
Hao‐Wen Sim, Evanthia Galanis, Mustafa Khasraw
Cancers (2022) Vol. 14, Iss. 4, pp. 1003-1003
Open Access | Times Cited: 39
The biology behind combining PARP and androgen receptor inhibition for metastatic castration resistant prostate cancer
Neeraj Agarwal, Tian Zhang, Eleni Efstathiou, et al.
European Journal of Cancer (2023) Vol. 192, pp. 113249-113249
Open Access | Times Cited: 20
Camptothecin loaded casein nanosystem for tuning the therapeutic efficacy against highly metastatic triple-negative breast cancer cells
Sajmina Khatun, Monika Pebam, Chandra Lekha Putta, et al.
Biomaterials Science (2023) Vol. 11, Iss. 7, pp. 2518-2530
Closed Access | Times Cited: 19
Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors
Xuexia Xie, Congcong Chen, Cong Wang, et al.
Redox Biology (2024) Vol. 76, pp. 103350-103350
Open Access | Times Cited: 6
Structure-based design, synthesis, and evaluation of inhibitors with high selectivity for PARP-1 over PARP-2
Yu Jiang, Lingling Luo, Tong Hu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113898-113898
Closed Access | Times Cited: 30
ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives
Giuseppe Manco, Giuseppina Lacerra, Elena Porzio, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 443-443
Open Access | Times Cited: 21
Strategies for the prevention or reversal of PARP inhibitor resistance
Zahi Mitri, Shaun Goodyear, Gordon B. Mills
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 10, pp. 959-975
Open Access | Times Cited: 4
Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose–High-Lipid Conditions: A Comparative Study
Esmaeel Ghasemi Gojani, Bo Wang, Dongping Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 421-421
Open Access
Triple-Negative Breast Cancer: Radiologic-Pathologic Correlation
Amrita Valluri, Gloria J Carter, Inna Robrahn, et al.
Journal of Breast Imaging (2025)
Closed Access
iNOS-Produced Nitric Oxide from Cancer Cells as an Intermediate of Stemness Regulation by PARP-1 in Colorectal Cancer
María del Moral-Martinez, Paula Sánchez-Uceta, Ruben Clemente-Gonzalez, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 125-125
Open Access
Washingtonia robusta H. Wendl Leaf Metabolites Potentiate the Radiosensitivity of Hepatocellular Carcinoma Through Ki67 and PARP Inhibition
Nabil M. Selim, Seham S. El‐Hawary, Soheir M. El Zalabani, et al.
Integrative Cancer Therapies (2025) Vol. 24
Open Access
PARP1: A comprehensive review of its mechanisms, therapeutic implications and emerging cancer treatments
Carlota J.F. Conceição, Elin Moe, Paulo A. Ribeiro, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189282-189282
Open Access
The PARP Enzyme Family and the Hallmarks of Cancer Part 2: Hallmarks Related to Cancer Host Interactions
Máté Á. Demény, László Virág
Cancers (2021) Vol. 13, Iss. 9, pp. 2057-2057
Open Access | Times Cited: 24
Decursin Induces G1 Cell Cycle Arrest and Apoptosis through Reactive Oxygen Species-Mediated Endoplasmic Reticulum Stress in Human Colorectal Cancer Cells in In Vitro and Xenograft Mod-Els
Danbee Kim, Seok-Ho Go, Young‐Ho Song, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9939-9939
Open Access | Times Cited: 3
Functions of ADP-ribose transferases in the maintenance of telomere integrity
Daniela Muoio, Natalie Laspata, Elise Fouquerel
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 4
Open Access | Times Cited: 16
Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review
Jiaqi Xiong, Ranya Barayan, Alexander V. Louie, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 521-542
Open Access | Times Cited: 16
Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer, Part 1: Technical Considerations
Stanislas Quesada, Michel Fabbro, Jérôme Solassol
Cancers (2022) Vol. 14, Iss. 5, pp. 1132-1132
Open Access | Times Cited: 13
Anterior gradient‐2 regulates cell communication by coordinating cytokine–chemokine signaling and immune infiltration in breast cancer
Shichao Zhang, Qin Liu, Yimei Wei, et al.
Cancer Science (2023) Vol. 114, Iss. 6, pp. 2238-2253
Open Access | Times Cited: 7
Small molecule tractable PARP inhibitors: Scaffold construction approaches, mechanistic insights and structure activity relationship
Amandeep Thakur, Mandeep Rana, Ritika Ritika, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106893-106893
Closed Access | Times Cited: 7
A Comprehensive Review on PARP Inhibitors in Targeted Therapy for Cancers
Mounika Guduri, Samyuktha Kolluru, Haritha Pasupulati, et al.
Deleted Journal (2024) Vol. 19, Iss. 2, pp. 44-59
Open Access | Times Cited: 2
The Potential of PARP Inhibitors as Antitumor Drugs and the Perspective of Molecular Design
Yinghan Wang, Jingtao Zhang, Xiaochen Wu, et al.
Journal of Medicinal Chemistry (2024) Vol. 68, Iss. 1, pp. 18-48
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top